Jeffrey F Yale is a Ansonia, Connecticut based male podiatrist who is specialized in Podiatry. Active license number of Jeffrey F Yale for Podiatry is 000231 in Connecticut. Jeffrey F Yale is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. He diagnose and treat foot diseases and deformities. He can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Jeffrey F Yale speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
DPM
Gender:
Male
Practice Address:
364 E Main St, Ansonia, Connecticut, 06401-1904
Phone:
203-734-4806
Fax:
203-734-8265
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790796845
NPI Enumeration Date:
11 Aug, 2006
NPI Last Update On:
24 Jan, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jeffrey F Yale are as mentioned below.
License Number
Specialization
State
Status
000231
Podiatry
Connecticut
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
364 E Main St, Ansonia, Connecticut
Zip:
06401-1904
Phone Number:
203-734-4806
Fax Number:
203-734-8265
Patients can reach Jeffrey F Yale at 364 E Main St, Ansonia, Connecticut or can call to book an appointment on 203-734-4806. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.